Variety of qualified sufferers: CDEC mentioned the uncertainty in the volume of sufferers with reasonably extreme to critical hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some individuals who're labeled as obtaining gentle or moderate condition could have a severe bleeding phenotype, which https://hemgenix93715.blogoscience.com/42105226/everything-about-hemgenix